0 Speaker List
 Joseph   Grogan Image

Joseph Grogan

Former Assistant to President Donald J. Trump and Director of the Domestic Policy Council

Travels From:
Washington, D.C.
Fee Range:
$15, 000 - $25,000

Joseph Grogan served as Assistant to President Donald J. Trump and Director of the Domestic Policy Council.  He was the President’s lead advisor on a variety of domestic policy issues relating to health care, regulatory and deregulatory initiatives, economic expansion, commercial space exploration, environment, agriculture, civil rights, and education. He is a health policy thought leader who has played a key role in the health sector’s most consequential debates of the last decade.

Featured Videos

The Future of Healthcare

Federation of American Hospitals Annual Meeting

Finding a Cure for the Cost of Durable Therapies

Bio

Joseph Grogan served as Assistant to President Donald J. Trump and Director of the Domestic Policy Council. He was the President’s lead advisor on a variety of domestic policy issues relating to health care, regulatory and deregulatory initiatives, economic expansion, commercial space exploration, environment, agriculture, civil rights, and education. He is a health policy thought leader who has played a key role in the health sector’s most consequential debates of the last decade.

Mr. Grogan was also a member of the White House’s COVID-19 Task Force, where he worked with Executive Branch officials to respond to the COVID-19 public health emergency.

During his time as Director of the Domestic Policy Council, Mr. Grogan led a White House team that directed the focus and attention of all major policy initiatives, including the development of regulations, Executive Orders, Presidential Decision Memorandums, and major Presidential announcements. In his role, Mr. Grogan coordinated with the President’s Cabinet, National Economic Council, White House Communications, Office of Management and Budget, and White House Legislative Affairs to drive the President’s domestic policy agenda. Notably, Mr. Grogan negotiated provisions of the 2020 Omnibus Spending Bill with Congressional leadership and members which eliminated a number of significant health care taxes. He developed a reputation as having an open door across the political spectrum for innovators and private industry seeking to solve complex problems in a highly regulated environment.

Before serving as Director of the Domestic Policy Council, Mr. Grogan was Associate Director for Health Programs at the Office of Management and Budget. During his tenure at the Office of Management and Budget, Mr. Grogan was responsible for overseeing all domestic health spending, totaling $1.3 trillion per year. Mr. Grogan also supervised the development of the President’s annual health budget, worked within the Executive Office of the President to formulate policy, and reviewed regulatory and administrative actions relating to Medicare, Medicaid, and other health programs to ensure they adhered to the President’s healthcare policy agenda. Mr. Grogan also provided technical assistance to Congress in drafting legislative proposals and managed a staff of 46 civil-service employees.

In the George W. Bush Administration, Mr. Grogan served as Senior Advisor to the Commissioner at the Food and Drug Administration, advising the Commissioner on a broad spectrum of food and drug regulatory issues. In the private sector, Mr. Grogan led the Washington Office for Gilead Sciences; and worked at Amgen and the Marwood Group.

Mr. Grogan is the author of numerous opinion pieces on prescription drug pricing, mental health, school choice programs, surprise medical billing, and Medicare spending. His articles have appeared in the New York Times, the Wall Street Journal, USA Today, Fox News, and the Washington Post.

Mr. Grogan holds a Juris Doctor from William and Mary School of Law. He also holds a Bachelor of Arts from the State University of New York at Albany.

Speech Topics

The Coronavirus has shown how the interwoven global economy can erode sovereignty and America’s ability to be self-reliant.  With medical product supply chains completely dependent on self-interested foreign governments, America has faced critical medical product shortages and lacked the ability to master its own response.  Additionally, international institutions, which arose out of the post -World War II order, have come under threat from foreign powers hostile to American values. Joe Grogan presents a perspective on how a more robust economy, which is based on personal and national resilience, is the best future for our country.  Grogan outlines a bold vision of a new globalism, in which America is the lion in partnering with, rather than depending on, foreign powers.


The COVID-19 pandemic presents an inflection point and opportunity in the fight against emerging infectious disease.  America can forge new and long-lasting partnerships between the government and the private sector in the areas of diagnostics, vaccines and antiviral development and delivery.  It is also the right moment to redesign America’s public health infrastructure so it can rapidly mobilize in the moment of national public health crises.  As a consistent advocate for institutional reform and member of the White House COVID-19 Taskforce, Joe Grogan had a seat at the table in understanding and guiding policy decisions, and provides perspectives on what are the next steps that need to be taken, and how to design lasting changes to address future pandemics.


A revolution in patient-centered health care provides an incredible opportunity to reframe the health reform debate.  The past discussion revolved around universal coverage, cost containment, and centralized planning.  The future is the empowerment of health care consumers through increased information and choices.  Vast innovation in technology and health information can help patients inform reform the system through their own choices.  Rather than government policy makers “redesigning” the health care system, there is an opportunity for patients to choose a system that works best for them.  The health policy agenda of the future includes pricing transparency so patients understand cost, interoperable medical records so patients can understand their health status and clear outcomes data so patients can understand the quality of results.  Additionally, options like telehealth solutions allow patients to get care where and when they want it.  Joe Grogan redefines “health reform,” and lays out a clear vision for what policy steps can be taken to foster patient-centered reform.


Medical breakthroughs present a new golden age for scientific advancement and patient treatment.  Years of medical technology investment and a more proactive FDA have produced significant breakthroughs on which government coverage and payment policies can be employed to broaden access.  Further, in the biopharmaceutical space, policies that promote market-based competition can help consumers get affordable access to prescription drugs.  Finally, over a series of decades, ad hoc, short term health policy and economic decisions have left America with a creaky, unstable reimbursement system that fails to value truly needed medical products.   A focused medical product discovery, development and manufacturing agenda can reduce our reliance on foreign supply chains, and produce more affordable and better results for patients.  Joe Grogan presents ideas on how payment policies can advance adoption of medical innovation, competition can unleash market powers to make products more affordable, and a focused medical product manufacturing agenda can produce better results.


Check Availability